BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 10939589)

  • 1. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome.
    An WG; Schulte TW; Neckers LM
    Cell Growth Differ; 2000 Jul; 11(7):355-60. PubMed ID: 10939589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts.
    Nimmanapalli R; O'Bryan E; Bhalla K
    Cancer Res; 2001 Mar; 61(5):1799-804. PubMed ID: 11280726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex.
    Shiotsu Y; Neckers LM; Wortman I; An WG; Schulte TW; Soga S; Murakata C; Tamaoki T; Akinaga S
    Blood; 2000 Sep; 96(6):2284-91. PubMed ID: 10979978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.
    Yorgin PD; Hartson SD; Fellah AM; Scroggins BT; Huang W; Katsanis E; Couchman JM; Matts RL; Whitesell L
    J Immunol; 2000 Mar; 164(6):2915-23. PubMed ID: 10706677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.
    Whitesell L; Sutphin PD; Pulcini EJ; Martinez JD; Cook PH
    Mol Cell Biol; 1998 Mar; 18(3):1517-24. PubMed ID: 9488468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.
    Whitesell L; Mimnaugh EG; De Costa B; Myers CE; Neckers LM
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8324-8. PubMed ID: 8078881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cell-based screen for inhibitors of protein folding and degradation.
    Boschelli F; Golas JM; Petersen R; Lau V; Chen L; Tkach D; Zhao Q; Fruhling DS; Liu H; Nam C; Arndt KT
    Cell Stress Chaperones; 2010 Nov; 15(6):913-27. PubMed ID: 20717760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geldanamycin-induced destabilization of Raf-1 involves the proteasome.
    Schulte TW; An WG; Neckers LM
    Biochem Biophys Res Commun; 1997 Oct; 239(3):655-9. PubMed ID: 9367823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome.
    Loo MA; Jensen TJ; Cui L; Hou Y; Chang XB; Riordan JR
    EMBO J; 1998 Dec; 17(23):6879-87. PubMed ID: 9843494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin.
    Wu LX; Xu JH; Zhang KZ; Lin Q; Huang XW; Wen CX; Chen YZ
    Leukemia; 2008 Jul; 22(7):1402-9. PubMed ID: 18418407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis.
    Gausdal G; Gjertsen BT; Fladmark KE; Demol H; Vandekerckhove J; Døskeland SO
    Leukemia; 2004 Dec; 18(12):1989-96. PubMed ID: 15483679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein.
    Bonvini P; Dalla Rosa H; Vignes N; Rosolen A
    Cancer Res; 2004 May; 64(9):3256-64. PubMed ID: 15126367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate.
    Thulasiraman V; Matts RL
    Biochemistry; 1996 Oct; 35(41):13443-50. PubMed ID: 8873613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
    Goasduff T; Cederbaum AI
    Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism.
    Fukazawa H; Uehara Y; Murakami Y; Mizuno S; Hamada M; Takeuchi T
    FEBS Lett; 1994 Mar; 340(3):155-8. PubMed ID: 8131836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinases.
    Sakagami M; Morrison P; Welch WJ
    Cell Stress Chaperones; 1999 Mar; 4(1):19-28. PubMed ID: 10467105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific association of a set of molecular chaperones including HSP90 and Cdc37 with MOK, a member of the mitogen-activated protein kinase superfamily.
    Miyata Y; Ikawa Y; Shibuya M; Nishida E
    J Biol Chem; 2001 Jun; 276(24):21841-8. PubMed ID: 11278794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptor deficient in chromatin binding has an altered cellular state.
    Botos J; Xian W; Smith DF; Smith CL
    J Biol Chem; 2004 Apr; 279(15):15231-9. PubMed ID: 14744870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
    Schulte TW; Neckers LM
    Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benzoquinone ansamycin geldanamycin stimulates proteolytic degradation of focal adhesion kinase.
    Ochel HJ; Schulte TW; Nguyen P; Trepel J; Neckers L
    Mol Genet Metab; 1999 Jan; 66(1):24-30. PubMed ID: 9973544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.